Overview


According to FutureWise analysis the market for Allergy Diagnostics in 2023 is US$ 5.95 billion, and is expected to reach US$ 14.03 billion by 2031 at a CAGR of 11.30%.

Allergy diagnostics refers to the process of identifying and determining the specific allergens that trigger allergic reactions in individuals. It involves various tests and procedures designed to diagnose and identify allergies accurately. Allergy diagnostics aims to help healthcare professionals understand a patient's allergic condition, identify the specific allergens causing the reactions, and develop an appropriate treatment plan. Allergy diagnostic tests can be categorized into two main types: in vivo and in vitro. In vivo, tests expose the patient to suspected allergens and observe the resulting reactions. Examples of in vivo tests include skin prick, intradermal, and patch tests. In vitro tests, on the other hand, are performed on blood samples and measure the presence of allergen-specific antibodies in the patient's blood. The most common type of in vitro test is the specific immunoglobulin E (IgE) blood test, also known as a serological test.

The prevalence of allergies has been steadily rising worldwide, significantly impacting public health. Allergic conditions, such as allergic rhinitis, asthma, food allergies, and drug allergies, affect a large population globally across all age groups. The rise in allergic diseases has led to a growing demand for accurate and reliable diagnostic tools that can help healthcare professionals in making informed decisions regarding patient management and treatment. The allergy diagnostics market is driven by various factors, including the increasing prevalence of allergies, advancements in diagnostic technologies, growing awareness among patients and healthcare providers, and effective treatment options.

FutureWise Market Research has published a report that provides an insightful analysis of allergy diagnostics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the allergy diagnostics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Thermo Fisher Scientific Inc.
  • Siemens Ag
  • Danaher Corporation
  • Omega Diagnostics Group Plc
  • Hitachi Chemical Co.,Ltd.
  • Biomérieux Sa
  •  Stallergenes Greer
  • Hob Biotech Group Suzhou Co.,Ltd.
  • Hycor Biomedical,Inc.
  • Lincoln Diagnostics,Inc.
  • R-Biopharm Ag

(Note: The list of the major players will be updated with the latest market scenario and trends)

The market growth of allergy diagnostics is driven by several key factors. One significant factor is the rising prevalence of allergy disorders, particularly among children and the geriatric population. Allergies have become increasingly common in recent years, affecting a noteworthy portion of the global population. The growing awareness and understanding of allergies have increased the number of individuals seeking diagnostic testing for allergic conditions. This trend fuels the demand for allergy diagnostic tools and drives the market growth. The increasing adoption of in vitro diagnostics (IVD) techniques is another factor contributing to the growth of the allergy diagnostics market. IVD techniques, such as immunoassays and molecular diagnostics, provide accurate and reliable results for the diagnosis of allergies. These techniques enable healthcare professionals to identify allergens causing allergic reactions and tailor appropriate treatment plans. The adoption of IVD techniques in clinical practice has improved the accuracy and efficiency of allergy diagnosis, leading to increased demand for diagnostic tools and driving the market growth. However, the adverse effects associated with conventional therapies for various medical conditions, including allergic disorders, have created a clinical urgency to develop a new generation of drugs with improved safety profiles. Common adverse effects of conventional therapies used for allergies, such as antihistamines or corticosteroids, include drowsiness, blurred vision, insomnia, and loss of appetite. These side effects can impact patients' quality of life and adherence to treatment regimens. Also, the development of new drug candidates involves extensive preclinical and clinical research, including target identification, drug discovery, and rigorous testing for efficacy and safety, which can further limit market growth.
 

By Product and Service

  • Assay Kits
  • Instruments
    • Immunoassay Analyzers
    • Luminometers
    • ELISA Analyzers
    • Other Instruments
  • Services

By Test Type

  • In Vivo Tests
  • In Vitro Tests

By Allergen

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

By End User

  • Diagnostics Laboratories
  • Hospital-based Laboratories
  • Academic and Research Institutes
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to elements including the rising allergy rates and the region's supportive government policies. In a developed region like North America, healthcare costs are considerable. In the near future, it is anticipated that regulatory organizations in North American nations will foster the advancement of medications. This is partly because these organizations are crucial in raising consumer awareness of the possibility of early detection and treatment of allergies. 

 
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Allergy Diagnostics Market By Product and Service, By Test Type, By Allergen, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Allergy Diagnostics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Allergy Diagnostics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Allergy Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Allergy Diagnostics Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Assay Kits
        2. Instruments
         2.1. Immunoassay Analyzers
         2.2. Luminometers
         2.3. ELISA Analyzers
         2.4. Other Instruments
        3. Services

  • 8.   Allergy Diagnostics Market, By Test Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. In Vivo Tests
        2. In Vitro Tests

  • 9.   Allergy Diagnostics Market, By Allergen Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Inhaled Allergens
        2. Food Allergens
        3. Drug Allergens
        4. Other Allergens

  • 10.   Allergy Diagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Diagnostics Laboratories
        2. Hospital-based Laboratories
        3. Academic and Research Institutes
        4. Other End Users

  • 11.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
             3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)

    •   1. Thermo Fisher Scientific Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Siemens Ag
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Danaher Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Omega Diagnostics Group Plc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hitachi Chemical Co.,Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biomérieux Sa
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Stallergenes Greer
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hob Biotech Group Suzhou Co.,Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Hycor Biomedical,Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Lincoln Diagnostics,Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. R-Biopharm Ag
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11